Seroepidemiological study of HBV infections in Athens, Greece

SUMMARY A seroepidemiological survey of a sample – roughly representative by age and sex – of 2744 persons of the Greater Athens area revealed that hepatitis B virus (HBV) infections are highly endemic in Greece. Hepatitis B surface antigen (HBsAg) was detected in 72 (2·6 %) of them. The subtype was identified in 70 of the 72 carriers, and 69 were ay; the other was ad. Determinant w was present in all 61 that were capable of being typed further, and a23y(w) was twice as common as a11y(w). Antibody to HBsAg (anti-HBs) was found in 514 (18·7%) persons. The prevalence of the HBsAg rose rapidly with age, reaching peak values (5·3%) at 20–29 years, while anti-HBs reached its highest value (42·1%) in older age groups (50–59 years). The frequency of HBsAg was significantly higher in males (3·4%) than in females (1·5%). The percentage of infected persons who become chronic HBsAg carriers (12·3%) was found higher than in other developed populations. It was also found higher in children (25%) than in adults (5·5%) and in males (14·6%) than in females (8·1%). These data indicate that HBV infection in early life is a major risk factor in the development of HBsAg carriers and support the hypothesis that males are more likely to become HBsAg carriers than females.

[1]  R. Hirsch,et al.  Hepatitis B surface antigen in blood donors: further observations. , 1975, The Journal of infectious diseases.

[2]  M. Benenson,et al.  An epidemiologic study of hepatitis B virus in Bangkok, Thailand. , 1975, American journal of epidemiology.

[3]  Hadziyannis Sj Chronic viral hepatitis. , 1974, Clinics in gastroenterology.

[4]  J. Hoofnagle,et al.  Exposure to hepatitis B virus and development of the chronic HBAg carrier state in children. , 1974, The Journal of pediatrics.

[5]  B. Blumberg,et al.  Geographical Distribution of Australia Antigen Determinants d, y and w , 1974, Nature.

[6]  G. Papaevangelou,et al.  Prevalence of hepatitis B antigen. , 1973, The Journal of infectious diseases.

[7]  W. Szmuness,et al.  The epidemiology of hepatitis B infections in Africa: results of a pilot survey in the Republic of Senegal. , 1973, American journal of epidemiology.

[8]  S. Krugman,et al.  Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention. , 1973, The New England journal of medicine.

[9]  W. Bancroft,et al.  Detection of additional antigenic determinants of hepatitis B antigen. , 1972, Journal of immunology.

[10]  A. Sutnick,et al.  Sex distribution of Australia antigen. , 1972, Archives of internal medicine.

[11]  R. Purcell,et al.  Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations. , 1972, Lancet.

[12]  J. Mosley,et al.  Subdeterminants d and y of hepatitis B antigen as epidemiologic markers. , 1972, American journal of epidemiology.

[13]  G. Bouvier The heterogeneity of Australia antigen. , 1971 .

[14]  G. L. Le Bouvier The heterogeneity of Australia antigen. , 1971, The Journal of infectious diseases.

[15]  R. W. Mccollum,et al.  Australia (Hepatitis-Associated) Antigen: Physicochemical And Immunological Characteristics* , 1970, Advances in Virus Research.

[16]  S. Sherlock,et al.  Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. , 1970, Lancet.

[17]  W P Havens,et al.  Viral hepatitis. , 1970, The Medical clinics of North America.